CAPRICOR THERAPEUTICS, INC. Increase (Decrease) in Interest Payable, Net
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase (Decrease) in Interest Payable, Net of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2019-03-29
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in interest payable, net for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in interest payable, net for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in interest payable, net for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in interest payable, net for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in interest payable, net for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in interest payable, net for fiscal 2017 was $398.81K, a 15.90% increase from fiscal 2016.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in interest payable, net for fiscal 2016 was $344.11K, a 39.47% increase from fiscal 2015.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in interest payable, net for fiscal 2015 was $246.72K, a 23.05% increase from fiscal 2014.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month | Increase (Decrease) in Interest Payable, Net 102 month | Increase (Decrease) in Interest Payable, Net 105 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | $0.00 10-K · filed 2019-03-29 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | $80.31K derived: sum of 4 quarters · filed 2019-03-29 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | $80.31K derived: sum of 3 quarters · filed 2019-03-29 | $187.96K derived: sum of 4 quarters · filed 2019-03-29 | ||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 | $80.31K derived: sum of 2 quarters · filed 2019-03-29 | $187.96K derived: sum of 3 quarters · filed 2019-03-29 | $293.49K derived: sum of 4 quarters · filed 2019-03-29 | ||
| 2017-12-31 | $80.31K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $187.96K derived: sum of 2 quarters · filed 2019-03-29 | $293.49K derived: sum of 3 quarters · filed 2019-03-29 | $398.81K 10-K · filed 2019-03-29 | ||
| 2017-09-30 | $107.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $213.18K derived: sum of 2 quarters · filed 2018-11-14 | $318.50K 10-Q · filed 2018-11-14 | $421.40K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $105.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $210.85K 10-Q · filed 2018-08-13 | $313.75K derived: sum of 3 quarters · filed 2018-08-13 | $412.50K derived: sum of 4 quarters · filed 2018-08-13 | ||
| 2017-03-31 | $105.32K 10-Q · filed 2018-05-14 | $208.22K derived: sum of 2 quarters · filed 2018-05-14 | $306.97K derived: sum of 3 quarters · filed 2018-05-14 | $383.64K derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | $102.91K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $201.65K derived: sum of 2 quarters · filed 2018-03-22 | $278.32K derived: sum of 3 quarters · filed 2018-03-22 | $344.11K 10-K · filed 2018-03-22 | ||
| 2016-09-30 | $98.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $175.41K derived: sum of 2 quarters · filed 2017-11-14 | $241.20K 10-Q · filed 2017-11-14 | $302.88K derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $76.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $142.45K 10-Q · filed 2017-08-14 | $204.13K derived: sum of 3 quarters · filed 2017-08-14 | $265.81K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $65.79K 10-Q · filed 2017-05-15 | $127.47K derived: sum of 2 quarters · filed 2017-05-15 | $189.15K derived: sum of 3 quarters · filed 2017-05-15 | $250.81K derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | $61.68K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $123.36K derived: sum of 2 quarters · filed 2017-03-16 | $185.02K derived: sum of 3 quarters · filed 2017-03-16 | $246.72K 10-K · filed 2017-03-16 | ||
| 2015-09-30 | $61.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $123.34K derived: sum of 2 quarters · filed 2016-11-14 | $185.04K 10-Q · filed 2016-11-14 | $245.43K derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $61.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $123.36K 10-Q · filed 2016-08-15 | $183.75K derived: sum of 3 quarters · filed 2016-08-15 | $243.84K derived: sum of 4 quarters · filed 2016-08-15 | ||
| 2015-03-31 | $61.71K 10-Q · filed 2016-05-13 | $122.09K derived: sum of 2 quarters · filed 2016-05-13 | $182.18K derived: sum of 3 quarters · filed 2016-05-13 | $236.88K derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2014-12-31 | $60.38K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $120.47K derived: sum of 2 quarters · filed 2016-03-30 | $175.18K derived: sum of 3 quarters · filed 2016-03-30 | $200.50K 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $60.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $114.80K derived: sum of 2 quarters · filed 2015-11-13 | $140.12K 10-Q · filed 2015-11-13 | $164.98K derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $54.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $80.03K 10-Q · filed 2015-08-14 | $104.89K derived: sum of 3 quarters · filed 2015-08-14 | $128.24K derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | $25.33K 10-Q · filed 2015-05-13 | $50.19K derived: sum of 2 quarters · filed 2015-05-13 | $73.54K derived: sum of 3 quarters · filed 2015-05-13 | $79.75K derived: sum of 4 quarters · filed 2015-05-13 | $83.46K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $24.86K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $48.21K derived: sum of 2 quarters · filed 2015-03-16 | $54.42K derived: sum of 3 quarters · filed 2015-03-16 | $58.13K 10-K · filed 2015-03-16 | $58.13K 10-K · filed 2014-03-31 | |
| 2013-09-30 | $23.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $29.56K derived: sum of 2 quarters · filed 2014-11-14 | $33.27K 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | $6.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $9.92K 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | $3.71K 10-Q · filed 2014-05-15 | |||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |